Literature DB >> 11213082

Vitamin E inhibits renal mRNA expression of COX II, HO I, TGFbeta, and osteopontin in the rat model of cyclosporine nephrotoxicity.

J K Jenkins1, H Huang, K Ndebele, A K Salahudeen.   

Abstract

BACKGROUND: In a rat model of cyclosporine (CsA) nephrotoxicity, vitamin E preserves renal function and reduces free radicals, vasoconstrictive thromboxanes, and tubulointerstitial fibrosis. We examined the effect of vitamin E on tubule gene expression in this model.
METHODS: In two of three groups, rats were treated with either CsA, or CsA plus vitamin E, whereas the control group received vehicles. We pooled purified tubules or whole kidney tissue in a novel manner to represent each treatment group, harvested RNA, and performed rigorously controlled qualitative reverse transcription-polymerase chain reaction.
RESULTS: Cyclooxygenase (COX) I mRNA was detectable in control animals, was increased by CsA, but was unchanged by vitamin E. COX II mRNA was detected in controls, was inhibited in the CsA group, and was further inhibited with vitamin E. Hemeoxygenase I and TGF-beta and osteopontin mRNA were increased in the CsA-treated group and were inhibited by vitamin E.
CONCLUSIONS: Our data support the involvement of free radicals, COX pathways, and pro-fibrotic genes in cyclosporine nephrotoxicity and suggest that the salutary effect of vitamin E involves the suppression of some of these genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11213082     DOI: 10.1097/00007890-200101270-00028

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Molecular diagnostics in transplantation.

Authors:  Maarten Naesens; Minnie M Sarwal
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

Review 2.  Vitamin E in renal therapeutic regiments.

Authors:  Mohamed Alaa Thabet; James C M Chan
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

3.  Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia.

Authors:  Tamara Egger; Rufina Schuligoi; Andrea Wintersperger; Rainer Amann; Ernst Malle; Wolfgang Sattler
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 4.  Therapeutic Implications of Ferroptosis in Renal Fibrosis.

Authors:  Yao Zhang; Yanhua Mou; Jianjian Zhang; Chuanjian Suo; Hai Zhou; Min Gu; Zengjun Wang; Ruoyun Tan
Journal:  Front Mol Biosci       Date:  2022-05-17

5.  Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.

Authors:  Masahiko Yano; Masanori Ikeda; Ken-Ichi Abe; Hiromichi Dansako; Shogo Ohkoshi; Yutaka Aoyagi; Nobuyuki Kato
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

Review 6.  Vitamin E administration as preventive measures for peritoneal/intra-abdominal adhesions: A systematic review and meta-analysis.

Authors:  Taufik Sudirman; Mochammad Hatta; Prihantono Prihantono; Agussalim Bukhari; Tjahyadi Robert Tedjasaputra; Hendry Lie
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

7.  α-Lipoic Acid Protects against Cyclosporine A-Induced Hepatic Toxicity in Rats: Effect on Oxidative Stress, Inflammation, and Apoptosis.

Authors:  Eman M El-Mancy; Dalia Mahmoud Abdelmonem Elsherbini; Rasha Hamed Al-Serwi; Mohamed El-Sherbiny; Gehan Ahmed Shaker; Abdel-Moneim Hafez Abdel-Moneim; Eman T Enan; Nehal M Elsherbiny
Journal:  Toxics       Date:  2022-08-02

8.  On the performance of trimetazidine and vitamin e as pharmacoprotection agents in cyclosporin a-induced toxicity.

Authors:  De la Cruz Rodríguez Lilia Cristina; Rey María Del Rosario; Araujo Carmen Rosa; Oldano Ana Veronica
Journal:  ISRN Pharmacol       Date:  2013-04-11

Review 9.  Established and newly proposed mechanisms of chronic cyclosporine nephropathy.

Authors:  Hye Eun Yoon; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.